Thank you for all the submissions. This call for abstracts is now closed

2023/02/28 23:59:00

This is a call for scientists, faculty, and collaborators, among others to submit abstracts that showcase their research studies and findings. As per our guidelines, abstracts will be peer-reviewed to determine their compliance with guidelines. Accepted abstracts/ posters authors will register for the event and agree to present in person.

Accepted abstracts will be published in a special Supplement of the Puerto Rico Health Sciences Journal.

Abstracts must be submitted online by February 28, 2023, 11:59 PM AST

Abstracts’ topics should be aligned with addressing the health needs of a growing U.S. Hispanic medically underserved population, specifically in the focus areas of:

      • chronic disease prevention
      • achievement of healthy lifestyles
      • emerging infectious diseases
      • health disparities
      • other related topics

Abstracts must comply with the Puerto Rico Health Sciences Journal (PRHSJ) guidelines. The official language is English.

No changes can be made after the abstract is submitted.

This year we will accept up to 40 posters to be presented at the scientific event.

  • Abstracts will be accepted for consideration with the understanding that they have not been published or presented (in part or in full) elsewhere.
  • Abstracts must be structured, briefly describing Purpose, Methods, Results, and Conclusion.
  • Abstracts must not exceed 250 words count [excluding title, authors, affiliations, funding and clinical trial information and IRB/IACUC approval number (if applicable)].
    • Note: Please, do not include tables.
  • Define all abbreviations the first time they appear in the abstract.
  • Do not include references.
  • Single space all typing.
  • Submit abstracts with a 12-point font.
  • Avoid use of ornate or script fonts.
  • Submit computer file of abstract. File must be in a PC-compatible format, preferably Microsoft Word.
  • Abstract must be organized using the following format:
      • TITLE: (upper-case letters, bold) maximum 100 characters (no spaces).
      • AUTHOR(S): (upper-lower case letters) Presenting author must be listed first. For each author, include first name, middle initial, last name, and highest degree(s) [MD, PhD, MS, etc.]. Separate author name from degree with comma; separate authors with semi-colon.
      • AFFILIATION(S): In a new line immediately following author(s) line, list institution(s) where work was performed. If more than one institution, indicate each author affiliation using numbers (superscript) and separate institutions with semi-colon.
      • BODY OF ABSTRACT: In a new line immediately following affiliation line, type the abstract describing PURPOSE, METHODS, RESULTS, CONCLUSION (header in upper-case letters, bold). Each section must start in a new line.
      • FUNDING (upper-lower case letters, bold): Authors are encouraged to acknowledge grant support for work (if applicable).
      • IRB/ IACUC approval number.
      • Note: For clinical trials, a trial registration heading should also be included (name of the trial registry, the registry URL and the trial registration number).

Abstracts will be evaluated by at least two reviewers including clinician, basic, behavioral, social, and translational researchers from local and national institutions. Reviewers will send their recommendations to the Research Abstract Committee (RAC). The primary criterion of evaluation will be the quality of the research, as reflected in the abstract. Evaluations will be made according to the following criteria:

  • Significance: Research study shows importance in scientific knowledge or clinical practices approaches.
  • Approach: The design, methods, and analyses are adequately developed, integrated, and well-reasoned. Research study objectives are clearly stated.
  • Innovation: Is the research study original and innovative? Does the project develop or employ novel concepts, approaches or methodologies, tools or technologies in the area studied?

The authors will be notified, via email, of the status of their abstracts no later than March 28, 2023. The author of the selected abstracts should submit the PDF poster by May 1, 2023. It is a requirement for the author or co-author(s), to present in person their research at the assigned date (May 3, 2023).

For updates on registration, agenda, and event details, please visit our website and stay tuned to our social media pages

For additional information contact Dr. Karen Pabón-Cruz, Professional Development Core (PDC) coordinator at or (787) 759-0306 Ext. 234.